Seasoned finance and operations executive with experience leading investment strategy, corporate development and portfolio company value creation in middle-market technology and services. Vickie Gutierrez combines hands-on operating leadership with experience structuring deals, capital raises and strategic partnerships, and has served in senior roles across growth-stage and PE-backed companies. Market-focused profile emphasizing operational turnarounds, margin improvement and scalable go-to-market execution; often active in board or advisory capacities supporting investor oversight. Relevant for investors seeking operators with cross-functional execution skills and deal execution experience.
Seasoned finance and operations executive with experience leading investment strategy, corporate development and portfolio company value creation in middle-market technology and services. Vickie Gutierrez combines hands-on operating leadership with experience structuring deals, capital raises and strategic partnerships, and has served in senior roles across growth-stage and PE-backed companies. Market-focused profile emphasizing operational turnarounds, margin improvement and scalable go-to-market execution; often active in board or advisory capacities supporting investor oversight. Relevant for investors seeking operators with cross-functional execution skills and deal execution experience.
Combines operator-first investing with pragmatic, value‑creation driven capital deployment focused on middle‑market technology and services. Prioritizes deals where operational turnarounds, margin expansion and scalable go‑to‑market playbooks can materially de‑risk growth; underwrites opportunities through hands‑on diligence, KPI‑led forecasting and focused capital for execution (buy‑and‑build, tuck‑ins, selective growth capital). Prefers medium-term horizons tied to execution milestones, active board or advisory involvement, tight cost and cash discipline, and partnerships that align management incentives with measurable operational milestones.
Combines operator-first investing with pragmatic, value‑creation driven capital deployment focused on middle‑market technology and services. Prioritizes deals where operational turnarounds, margin expansion and scalable go‑to‑market playbooks can materially de‑risk growth; underwrites opportunities through hands‑on diligence, KPI‑led forecasting and focused capital for execution (buy‑and‑build, tuck‑ins, selective growth capital). Prefers medium-term horizons tied to execution milestones, active board or advisory involvement, tight cost and cash discipline, and partnerships that align management incentives with measurable operational milestones.
| Trades 196 | Longs Won 137/196 69% | Profit Factor 7.23 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $233,331.93 |
| Average Win $101,314.06 | Best Trade (Aug 15) $2.12M | Sharpe Ratio -1,264.57 |
| Average Loss -$32,550.37 | Worst Trade (Aug 19) -$415,763.06 | Z-Score 5.8 (100%) |
| Commissions $0 | Avg. Trade Length 6m 3w 6d | Expectancy $61,009.03 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 3,460 | 3,114 | 2,768 | 2,422 | 2,076 | 1,730 | 1,384 | 1,038 | 692 | 346 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 6,725 | $1.71M | $2.06M | - | $345,039.11 | 20.15% | +0.219% |
ABBV AbbVie Inc. | 2,211 | $511,764.37 | $551,556.08 | - | $39,791.71 | 7.78% | -0.542% |
ABT Abbott Laboratories | 3,279 | $438,505.65 | $364,788.75 | - | -$73,716.9 | -16.81% | -0.018% |
AMAT Applied Materials, Inc. | 601 | $205,416 | $304,815.17 | - | $99,399.17 | 48.39% | -5.118% |
AMGN Amgen Inc. | 609 | $199,853.52 | $252,862.88 | - | $53,009.36 | 26.52% | -0.629% |
AMZN Amazon.com Inc | 3,995 | $873,114.16 | $1.05M | - | $176,172.55 | 20.18% | -0.935% |
BRK-B Berkshire Hathaway Inc. | 898 | $451,460.93 | $452,618.94 | - | $1,158.01 | 0.26% | -0.572% |
BRO Brown & Brown Inc. | 6,101 | $533,705.69 | $430,364.54 | - | -$103,341.15 | -19.36% | -1.494% |
CL Colgate-Palmolive Company | 3,300 | $264,052.25 | $303,435 | - | $39,382.75 | 14.91% | -1.055% |
CLX The Clorox Company | 7,680 | $946,944 | $811,776 | - | -$135,168 | -14.27% | -0.788% |
CVS CVS Health Corporation | 3,000 | $226,170 | $291,480 | - | $65,310 | 28.88% | +2.284% |
CVX Chevron Corporation | 3,269 | $508,436.39 | $653,800 | - | $145,363.61 | 28.59% | +1.163% |
| EVMO EVMO | 109,512 | $5.55M | $5.56M | - | $1,785.03 | 0.03% | 0.0 |
EW Edwards Lifesciences Corporation | 3,315 | $258,581.28 | $303,654 | - | $45,072.72 | 17.43% | -1.037% |
FESM Fidelity Enhanced Small Cap ETF | 154,613 | $5.84M | $7.56M | - | $1.72M | 29.38% | +0.493% |
GLDM SPDR Gold MiniShares Trust | 35,184 | $2.69M | $3.05M | - | $356,413.61 | 13.25% | +0.616% |
GOOG Alphabet Inc | 3,732 | $911,598.4 | $1.28M | - | $370,492.92 | 40.64% | -0.116% |
GOOGL Alphabet Inc | 2,702 | $656,855.93 | $934,621.77 | - | $277,765.84 | 42.29% | -0.133% |
GPIX S&P 500 Core Premium Income Fund | 64,984 | $3.43M | $3.68M | - | $250,809.35 | 7.32% | -0.106% |
HAL Halliburton Company | 7,456 | $210,707 | $256,635.52 | - | $45,928.52 | 21.8% | +4.811% |